Detection of survivin and p53 in human oral cancer: Correlation with clinicopathologic findings

Head and Neck

Volumn 31, Issue 8, 2009, Pages 1039-1048

  Khan, Zakir ^a,f   Tiwari, Ram P ^b,g   Mulherkar, Rita ^c   Sah, Nand K ^a   Prasad, Godavarthi B K S ^d   Shrivastava, Braj R ^e   Bisen, Prakash S ^a  

^a MADHAV INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b Piramal Enterprises Limited   (India)

^c TATA MEMORIAL HOSPITAL   (India)

^d JIWAJI UNIVERSITY   (India)

^e Cancer Hospital   (India)

^f INSERM   (France)

^g Production and Development Division   (Nigeria)

Author keywords

Apoptosis; Immunohistochemistry; Oral squamous cell carcinoma (OSCC); p53; Survivin

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; PROTEIN P53; SURVIVIN;

ADULT; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FISHER EXACT TEST; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOPLAKIA, ORAL; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROBABILITY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 67650451183     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21071     Document Type: Article

References (40)

1. Scully C, Porter S. ABC of oral health: oral cancer. BMJ 2000;321:97-100.
2. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195-215.
3. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003;260:502-508. (Pubitemid 37363578)
4. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994;76:777-779.
5. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
6. Nagata S. Apoptosis and autoimmune diseases. IUBMB Life 2006;58:358-362.
7. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
8. Aravind L, Dixit V, Mand Koonin EV. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci 1999;24:47-53. (Pubitemid 29346572)
9. Mawji IA, Simpson CD, Hurren R, et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 2007;99:811-822. (Pubitemid 47073526)
10. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999;17:2941-2953.
11. Li F, Ackermann EJ, Bennett CF, et al. Pleiotropic celldivision defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999;1:461-466. (Pubitemid 129503664)
12. Lu C-D, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998;58:1808-1812. (Pubitemid 28217451)
13. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 1996;88:1456-1462. (Pubitemid 26240369)
14. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptotic gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921. (Pubitemid 27353455)
15. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-49. (Pubitemid 28028045)
16. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-584 (Pubitemid 28563719)
17. Khan Z, Bhadouria P, Gupta R, Bisen PS. Tumor control by manipulation of the human anti-apoptotic survivin gene. Curr Cancer Ther Rev 2006;2:73-79. (Pubitemid 44082906)
18. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-252.
19. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998;58:5071-5074. (Pubitemid 28521163)
20. Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small-cell lung cancers. J Clin Oncol 1999;17:2100-2104. (Pubitemid 29318841)
21. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000;6:127-134. (Pubitemid 30064984)
22. Islam A, Kageyama H, Takada N, et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000;19:617-623. (Pubitemid 30102912)
23. Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001;95: 92-95. (Pubitemid 32187079)
24. Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of oesophageal carcinogenesis. Am J Surg Pathol 1995;19:1418-1422. (Pubitemid 3007347)
25. Jane C, Nerurkar AV, Shirsat NV, Deshpande RB, Amrapurkar AD, Karjodkar FR. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers. J Oral Pathol Med 2006;35:595-601. (Pubitemid 44525636)
26. Freier K, Pungs S, Sticht C, et al. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Int J Cancer 2007;120:942-946. (Pubitemid 46175418)
27. Lo Muzio L, Staibano S, Pannone G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001;70:249-254. (Pubitemid 32607197)
28. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002;22: 2377-2383. (Pubitemid 34857069)
29. Gianani R, Jarboe E, Orlicky D, et al. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 2001;32:119-125. (Pubitemid 32150638)
30. Grossman D, McNiff JM, Li F, Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-1081. (Pubitemid 30013356)
31. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001; 92:271-278. (Pubitemid 32664432)
32. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91. (Pubitemid 26008141)
33. Brachman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papillomavirus infection in human head and neck cancer. Cancer Res 1992;62: 4832-4836.
34. Shin DM, Lee JS, Choi LG. Prognostic significance of p53 expression in head and neck squamous cell carcinoma. Proc Am Soc Clin Oncol 1994;13:283-289.
35. Levine AL. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331. (Pubitemid 27131374)
36. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2000;277:3247-3257.
37. Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002;21:2613-2622. (Pubitemid 34478319)
38. Zhang T, Otevrel T, Gao Z, Ehrich SM, Fields JZ. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001;61:8664-8667. (Pubitemid 34013874)
39. Greenblat MS, Bennett WP, Hollstein M, Harris C. Mutations in the p53 tumor suppressor genes: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878. (Pubitemid 24289415)
40. Chiang CP, Lang MJ, Liu BY, et al. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkerotosis and oral epithelial dysplasis. J Formos Med Assoc 2000;99:229-234. (Pubitemid 30262810)